P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).

Authors

null

Namrata Nayar

NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia

Namrata Nayar , Nicola Jane Lawrence , Martin R. Stockler , Andrew James Martin , Sonia Yip , Nicole Wong , Annie Yeung , Michael Friedlander , Danish Mazhar , Farzana Pashankar , David I. Quinn , Ray McDermott , Rick Walker , Mark Winstanley , Fritha J. Hanning , Andrew James Weickhardt , Amanda Gwendolyn Stevanovic , Ian D. Davis , Guy C. Toner , Peter S. Grimison

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Clinical Trial Registration Number

NCT02582697

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS574)

DOI

10.1200/JCO.2018.36.6_suppl.TPS574

Abstract #

TPS574

Poster Bd #

P2

Abstract Disclosures